Cargando…

Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson’s Disease Mouse Model

Chronic neuroinflammation has been considered to be involved in the progressive dopaminergic neurodegeneration in Parkinson’s disease (PD). However, the mechanisms remain unknown. Accumulating evidence indicated a key role of the blood–brain barrier (BBB) dysfunction in neurological disorders. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Zhengzheng, Zhang, Dongdong, Huang, Ruixue, Sun, Wei, Hou, Liyan, Zhao, Jie, Wang, Qingshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910886/ https://www.ncbi.nlm.nih.gov/pubmed/35269933 http://dx.doi.org/10.3390/ijms23052793

Ejemplares similares

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
por: Zhang, Dongdong, et al.
Publicado: (2021)

Microglial Activation Mediates Noradrenergic Locus Coeruleus Neurodegeneration via Complement Receptor 3 in a Rotenone-Induced Parkinson’s Disease Mouse Model
por: Jing, Lu, et al.
Publicado: (2021)

Taurine protects dopaminergic neurons in a mouse Parkinson’s disease model through inhibition of microglial M1 polarization
por: Che, Yuning, et al.
Publicado: (2018)

Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
por: Cai, Hua-Ying, et al.
Publicado: (2021)

Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase–NLRP3 inflammasome axis-dependent microglial activation
por: Hou, Liyan, et al.
Publicado: (2023)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
por: Chung, Young Cheul, et al.
Publicado: (2013)

Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
por: Jiang, Lulu, et al.
Publicado: (2016)

2,5-Hexanedione induces dopaminergic neurodegeneration through integrin α(M)β2/NADPH oxidase axis-mediated microglial activation
por: Zhang, Cong, et al.
Publicado: (2018)

Correction: 2,5-Hexanedione induces dopaminergic neurodegeneration through integrin α(M)β2/NADPH oxidase axis-mediated microglial activation
por: Zhang, Cong, et al.
Publicado: (2022)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Diosgenin Prevents Microglial Activation and Protects Dopaminergic Neurons from Lipopolysaccharide-Induced Neural Damage In Vitro and In Vivo
por: Lee, Shou-Lun, et al.
Publicado: (2021)

Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation
por: Liu, Jie, et al.
Publicado: (2015)

Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson’s Disease Models
por: Huang, Bingxu, et al.
Publicado: (2017)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson’s Disease
por: Okuyama, Satoshi, et al.
Publicado: (2016)

Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation
por: Zhang, Ruiping, et al.
Publicado: (2011)

Cytokine Profiling in Human iPSC-Derived Dopaminergic Neuronal and Microglial Cultures
por: Knappe, Evelyn, et al.
Publicado: (2023)

Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model
por: Hou, Liyan, et al.
Publicado: (2019)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65
por: Lin, Zixuan, et al.
Publicado: (2021)

Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson’s disease model
por: Hou, Liyan, et al.
Publicado: (2020)

1α,25-Dihydroxyvitamin D(3) Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation
por: Kim, Joong-Seok, et al.
Publicado: (2006)

Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
por: Walsh, Jessica, et al.
Publicado: (2021)

HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson's disease cell and mouse models
por: Lun, Peng, et al.
Publicado: (2021)

Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss
por: Song, Dae-Yong, et al.
Publicado: (2013)

DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson’s disease
por: Kinugawa, Kiyoka, et al.
Publicado: (2013)

Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats
por: Li, Xiao-Qian, et al.
Publicado: (2014)

In situ analysis of acupuncture protecting dopaminergic neurons from lipid peroxidative damage in mice of Parkinson's disease
por: Zuo, Tingting, et al.
Publicado: (2022)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons
por: Wang, Shijun, et al.
Publicado: (2016)

JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss
por: Wang, Qing, et al.
Publicado: (2018)

Inhibition of Nigral Microglial Activation Reduces Age-Related Loss of Dopaminergic Neurons and Motor Deficits
por: Wang, Tzu-Feng, et al.
Publicado: (2022)

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
por: Wang, Qingshan, et al.
Publicado: (2012)

FOXA1 transcription activates TFF1 to reduce 6-OHDA-induced dopaminergic neuron damage
por: Liang, Tingting, et al.
Publicado: (2022)

Quercetin and Sesamin Protect Dopaminergic Cells from MPP(+)-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System
por: Bournival, Julie, et al.
Publicado: (2012)

Changes in MMP-2, MMP-9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis
por: Bai, Xuesong, et al.
Publicado: (2020)

Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models
por: Lu, Tao, et al.
Publicado: (2017)

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis
por: McNeill, Alisdair, et al.
Publicado: (2013)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mvcs7t926rimjt4cennkps80tt